Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Daniel D. Burgess currently holds 20,500 shares of Nabriva Therapeutics plc (NBRV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel D. Burgess has been a net seller of NBRV stock. They have purchased $147.0K and sold $682.6K worth of shares.
Daniel D. Burgess's most recent insider trade was on Dec 17, 2024, when they sold 20,500 shares at $0.00 per share.
Daniel D. Burgess serves as Executive at Nabriva Therapeutics plc (NBRV). They have executed 24 insider transactions totaling $829.6K over their tenure at the company.
Daniel D. Burgess holds the position of Executive at Nabriva Therapeutics plc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Daniel D. Burgess has shown a selling trading pattern, with $147.0K in total purchases and $682.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Daniel D. Burgess was on Jun 3, 2013, when they sold $170.7K worth of SNTS shares. This transaction involved 8,000 shares at $21.34 per share.
Daniel D. Burgess currently owns 20,500 shares of Nabriva Therapeutics plc (NBRV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Daniel D. Burgess's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Daniel D. Burgess has 24 Form 4 filings on record as an insider at Nabriva Therapeutics plc.
Set alerts for Daniel D. Burgess and 40,000+ other insiders.